Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin (Q33302297)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin |
scientific article |
Statements
1 reference
Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin (English)
1 reference
Daniel V Paone
1 reference
Anthony W Shaw
1 reference
Diem N Nguyen
1 reference
Christopher S Burgey
1 reference
James Z Deng
1 reference
Stefanie A Kane
1 reference
Kenneth S Koblan
1 reference
Christopher A Salvatore
1 reference
Scott D Mosser
1 reference
Victor K Johnston
1 reference
Bradley K Wong
1 reference
Cynthia M Miller-Stein
1 reference
James C Hershey
1 reference
Samuel L Graham
1 reference
Joseph P Vacca
1 reference
Theresa M Williams
1 reference
11 October 2007
1 reference
1 reference
50
1 reference
23
1 reference
5564-5567
1 reference
Identifiers
1 reference
1 reference